Matt Abernethy

Chief Financial Officer at Neurocrine Biosciences · 10 reported transactions in 1 company · latest report Feb 13, 2026

Their trades


Neurocrine BiosciencesNBIX	Shares withheld for tax $667.5K · 5,378 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Share award — · 9,968 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Shares withheld for tax $171.9K · 1,385 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Exercised options — · 2,566 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Shares withheld for tax $150.2K · 1,210 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Exercised options — · 2,241 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Shares withheld for tax $141.7K · 1,151 shares	Feb 12, 2026
Neurocrine BiosciencesNBIX	Exercised options — · 2,133 shares	Feb 12, 2026
Neurocrine BiosciencesNBIX	Shares withheld for tax $186.1K · 1,368 shares	Jan 31, 2026
Neurocrine BiosciencesNBIX	Exercised options — · 2,437 shares	Jan 31, 2026

Shares withheld for taxNeurocrine Biosciences

Feb 13, 2026 · NBIX

$667.5K

Share awardNeurocrine Biosciences

Feb 13, 2026 · NBIX

9,968

Shares withheld for taxNeurocrine Biosciences

Feb 13, 2026 · NBIX

$171.9K

Exercised optionsNeurocrine Biosciences

Feb 13, 2026 · NBIX

2,566

Shares withheld for taxNeurocrine Biosciences

Feb 13, 2026 · NBIX

$150.2K

Exercised optionsNeurocrine Biosciences

Feb 13, 2026 · NBIX

2,241

Shares withheld for taxNeurocrine Biosciences

Feb 12, 2026 · NBIX

$141.7K

Exercised optionsNeurocrine Biosciences

Feb 12, 2026 · NBIX

2,133

Shares withheld for taxNeurocrine Biosciences

Jan 31, 2026 · NBIX

$186.1K

Exercised optionsNeurocrine Biosciences

Jan 31, 2026 · NBIX

2,437

10 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

← Back

Matt Abernethy

Chief Financial Officer at Neurocrine Biosciences · 10 reported transactions in 1 company · latest report Feb 13, 2026

Their trades


Neurocrine BiosciencesNBIX	Shares withheld for tax $667.5K · 5,378 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Share award — · 9,968 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Shares withheld for tax $171.9K · 1,385 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Exercised options — · 2,566 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Shares withheld for tax $150.2K · 1,210 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Exercised options — · 2,241 shares	Feb 13, 2026
Neurocrine BiosciencesNBIX	Shares withheld for tax $141.7K · 1,151 shares	Feb 12, 2026
Neurocrine BiosciencesNBIX	Exercised options — · 2,133 shares	Feb 12, 2026
Neurocrine BiosciencesNBIX	Shares withheld for tax $186.1K · 1,368 shares	Jan 31, 2026
Neurocrine BiosciencesNBIX	Exercised options — · 2,437 shares	Jan 31, 2026

Shares withheld for taxNeurocrine Biosciences

Feb 13, 2026 · NBIX

$667.5K

Share awardNeurocrine Biosciences

Feb 13, 2026 · NBIX

9,968

Shares withheld for taxNeurocrine Biosciences

Feb 13, 2026 · NBIX

$171.9K

Exercised optionsNeurocrine Biosciences

Feb 13, 2026 · NBIX

2,566

Shares withheld for taxNeurocrine Biosciences

Feb 13, 2026 · NBIX

$150.2K

Exercised optionsNeurocrine Biosciences

Feb 13, 2026 · NBIX

2,241

Shares withheld for taxNeurocrine Biosciences

Feb 12, 2026 · NBIX

$141.7K

Exercised optionsNeurocrine Biosciences

Feb 12, 2026 · NBIX

2,133

Shares withheld for taxNeurocrine Biosciences

Jan 31, 2026 · NBIX

$186.1K

Exercised optionsNeurocrine Biosciences

Jan 31, 2026 · NBIX

2,437

10 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Their trades

Others trading the same companies

Their trades

Others trading the same companies